Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,275,297 | 4,286,377 | 11,619,760 | 1,050,204 | 155,878 |
| Marketable Securities | 9,953,042 | 7,034,569 | 1,806,449 | 135,248 | 50,274 |
| Receivables | 450,722 | 609,489 | 952,402 | 253,487 | 113,736 |
| Inventories | 139,874 | 180,719 | 375,511 | 105,813 | 27,846 |
| Other current assets | 4 | 4 | 1 | 0 | 0 |
| TOTAL | $11,830,560 | $12,126,400 | $14,915,110 | $1,560,293 | $349,607 |
| Non-Current Assets | |||||
| PPE Net | 979,617 | 993,781 | 903,298 | 200,371 | 74,310 |
| Investments And Advances | 684,285 | 661,440 | 655,835 | 0 | 0 |
| Intangibles | 8,520 | 9,699 | 1,480 | 1,474 | 0 |
| Other Non-Current Assets | 154,996 | 323,252 | 272,452 | 139,188 | 28,382 |
| TOTAL | $1,827,418 | $1,988,172 | $1,833,065 | $341,033 | $102,692 |
| Total Assets | $13,657,970 | $14,114,570 | $16,748,170 | $1,901,326 | $452,299 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 76,089 | 293 | 3,099 | 32,941 | 5,934 |
| Accounts payable and accrued liabilities | 973,949 | 905,923 | 1,020,651 | 211,428 | 58,890 |
| Other current liabilities | 1,586 | 15,120 | 12,559 | 15,159 | 2,738 |
| TOTAL | $1,147,904 | $1,091,635 | $2,412,846 | $679,610 | $87,199 |
| Non-Current Liabilities | |||||
| Long Term Debt | 177,817 | 11,513 | 17,376 | 8,285 | 1,436 |
| Deferred Revenues | 20,127 | 17,955 | 79,941 | 364,005 | 5,462 |
| Other Non-Current Liabilities | 204,012 | 82,968 | -5,873,652 | 15,772 | -8,817 |
| TOTAL | $487,303 | $310,272 | $459,319 | $101,591 | $12,905 |
| Total Liabilities | $1,635,207 | $1,401,907 | $2,872,165 | $781,201 | $100,104 |
| Shareholders' Equity | |||||
| Common Shares | 100 | 100 | 100 | 99 | 99 |
| Retained earnings | 7,118,516 | 7,225,987 | 7,141,819 | 144,241 | 56,731 |
| Other shareholders' equity | 4,362,881 | 4,945,976 | 6,186,385 | 436,846 | 87,388 |
| TOTAL | $12,022,770 | $12,712,660 | $13,876,010 | $1,120,125 | $352,195 |
| Total Liabilities And Equity | $13,657,977 | $14,114,567 | $16,748,175 | $1,901,326 | $452,299 |